Your browser doesn't support javascript.
loading
Sodium 4-Phenylbutyrate Reduces Ocular Hypertension by Degrading Extracellular Matrix Deposition via Activation of MMP9.
Maddineni, Prabhavathi; Kasetti, Ramesh B; Kodati, Bindu; Yacoub, Sam; Zode, Gulab S.
Affiliation
  • Maddineni P; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.
  • Kasetti RB; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.
  • Kodati B; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.
  • Yacoub S; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.
  • Zode GS; Department of Pharmacology and Neuroscience, North Texas Eye Research Institute, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX 76107, USA.
Int J Mol Sci ; 22(18)2021 Sep 18.
Article in En | MEDLINE | ID: mdl-34576258
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phenylbutyrates / Ocular Hypertension / Matrix Metalloproteinase 9 / Extracellular Matrix / Eye Diseases Limits: Animals / Humans / Male Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phenylbutyrates / Ocular Hypertension / Matrix Metalloproteinase 9 / Extracellular Matrix / Eye Diseases Limits: Animals / Humans / Male Language: En Year: 2021 Type: Article